Publication | Closed Access

Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids

Multicentric Castleman DiseaseSclerodermaTafro SyndromeImmunologyAnti-il-6 Receptor AntibodyPathologyNeuropathologyMedicine